|
ZNF512 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.34799999998536E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.393700E-04 |
| Normal-vs-Stage2 |
1.626500E-04 |
| Normal-vs-Stage3 |
2.64110000536277E-08 |
| Normal-vs-Stage4 |
1.09059999997552E-06 |
| Stage1-vs-Stage2 |
1.322190E-01 |
| Stage1-vs-Stage3 |
2.955800E-03 |
| Stage1-vs-Stage4 |
1.630390E-02 |
| Stage2-vs-Stage3 |
5.507800E-01 |
| Stage2-vs-Stage4 |
5.215400E-01 |
| Stage3-vs-Stage4 |
8.537000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.34769999954921E-07 |
| Normal-vs-AfricanAmerican |
1.012420E-01 |
| Normal-vs-Asian |
1.094100E-02 |
| Caucasian-vs-AfricanAmerican |
1.259210E-01 |
| Caucasian-vs-Asian |
1.506590E-01 |
| AfricanAmerican-vs-Asian |
6.936200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.592180E-04 |
| Normal-vs-Female |
1.89470000000469E-06 |
| Male-vs-Female |
7.437400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.176200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.27689999999781E-05 |
| Normal-vs-Age(61-80Yrs) |
5.08759999684472E-08 |
| Normal-vs-Age(81-100Yrs) |
3.644700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.389240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.859500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.794630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.552000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.033200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.267200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.15699999997587E-06 |
| Classical-VS-Follicular |
5.800400E-03 |
| Classical-VS-Other |
9.596400E-01 |
| Classical-VS-Normal |
4.420500E-04 |
| Tall-VS-Follicular |
6.534400E-02 |
| Tall-VS-Other |
1.665160E-01 |
| Tall-VS-Normal |
2.1100999836321E-09 |
| Follicular-VS-Other |
4.087800E-01 |
| Follicular-VS-Normal |
3.1924000000183E-06 |
| Other-VS-Normal |
1.739390E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97836999999979E-05 |
| Normal-vs-N1 |
4.05189999996836E-06 |
| N0-vs-N1 |
4.260600E-01 |
|
|
